ArticleSAGE open medicine2026
Prevalence, severity and multidimensional factors associated with pain among hemodialysis patients: A cross-sectional study in a resource-limited healthcare system.
Article in SAGE open medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to determine the prevalence, severity and multidimensional factors associated with pain among hemodialysis (HD) patients in a resource-limited healthcare system. Methods: A multicenter cross-sectional study was conducted across eight hospitals in the West Bank of Palestine, enrolling 361 adult patients on maintenance HD. Pain intensity was measured using the Visual Analog Scale (VAS), pain interference with the Brief Pain Inventory (BPI) and health-related quality of life with the EuroQol 5-Dimension 5-Level (EQ-5D-5L). Results: Pain was reported by 281 patients, corresponding to a prevalence of 77.8%, with more than half (53.8%) experiencing moderate to severe intensity. Gender (OR = 2.29, 95% CI: 1.17-4.50), comorbid chronic diseases (OR = 3.62, 95% CI: 1.59-8.23), and HD vintage (OR = 1.12, 95% CI: 1.04-1.20) were independently associated with presence of pain. Pain severity was higher among females (B = 0.86, p = 0.006) and those with longer HD vintage (B = 0.05, p = 0.047), while smoking was linked to lower scores (B = -0.59, p = 0.006). Pain interference was higher in females (B = 1.23, p < 0.001) and patients with chronic diseases (B = 1.46, p = 0.001). Lower EQ-5D utility values were associated with age (β = -0.19, p = 0.003) and regular exercise (B = -0.14, p = 0.011). Self-assessed health scores declined with age (B = -0.23, p < 0.001) and chronic diseases (B = -4.69, p = 0.041). Pain control effectiveness was negatively associated with employment status (B = -2.53, p = 0.001). Conclusion: Pain is highly prevalent and undertreated among HD patients. The findings underscore the need for multidisciplinary, culturally sensitive strategies integrating pharmacologic, non-pharmacologic, psychosocial and spiritual care to better manage pain and enhance patient quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.